Table 3. Statistical analyses.
Question | Age | Gender | Education | Number of previous studies at CMAX Clinical Research | Ethnicity | |
---|---|---|---|---|---|---|
Is genetic security important to you? | p = 0.017 | ns | ns | ns | ns | |
Is genetic privacy important to you? | ns | ns | ns | ns | ns | |
Do you think incidental findings should be mentioned in the information sheet? | ns | ns | ns | ns | ns | |
Do you think it is important to be informed of any incidental findings? | ns | ns | ns | ns | ns | |
If your genetic information is re-analysed, how important is it you are informed of these results? | ns | ns | ns | ns | na | |
What risk level would you accept for the following diseases? | ||||||
Cancer | p = 0.035 | ns | ns | p = 0.006 | ns | |
Heart disease | p = 0.004 | ns | ns | p = 0.010 | ns | |
Neurodegeneration | p = 0.0001 | ns | ns | p = 0.015 | ns | |
Would you trade the privacy of your genetic information for re-identifiability in a future outcome? | ns | p = 0.033 | ns | ns | ns | |
Rank your personal information in terms of how important the security of the information is to you | ns | ns | ns | ns | ns | |
If you had a 50% risk of developing a potentially fatal form of untreatable cancer would you want results returned? | ns | ns | ns | ns | ns |
ns, not statistically significant; na, not applicable.